Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy

J Gordon Millichap

doi:10.15844/pedneurbriefs-24-3-3

Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy

Pediatric Neurology Briefs

Volume 24 (2010): Issue 3

By: J Gordon Millichap

Open Access

|Mar 2010

Abstract

Efficacy, tolerability, and neuropsychological effects of ethosuximide, valproic acid, and lamotrigine in children with newly diagnosed childhood absence epilepsy were compared in a double-blind, randomized, controlled clinical trial performed at six centers in the US and organized as a Study Group.

References

Glauser TA Cnaan A Shinnar S Hirtz DG Dlugos D Masur D Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy N Engl J Med 2010 Mar 4 362 9 790 799 10.1056/NEJMoa0902014 20200383
Open DOI Search in Google Scholar Back to article
Vining EP Ethosuximide in childhood absence epilepsy--older and better N Engl J Med 2010 Mar 4 362 9 843 845 10.1056/NEJMe0911874 20200390
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-24-3-3 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 19 - 19

Published on: Mar 1, 2010

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Neuropsychological Effects,

Valproic Acid,

Attentional Dysfunction

© 2010 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 24 (2010): Issue 3